Loncom Pharma's Anti-cancer Drugs, like Erlotinib Hydrochloride Tablet and Sunitinib Malate Capsule, represent cutting-edge oncology treatments. These drugs inhibit specific cancer-related pathways, providing new avenues for cancer patients.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
